Mkts

Globus Medical, Inc.

NYSE: GMED
$76.37+5.32 (+7.49%)
As of Nov 9, 4:00 PM ET

Key statistics

Day range
71.9176.69
52-week range
60.36101.40
Today
Open72.12
Previous close76.37
Volume—
Valuation
Market cap9.54B
P/E ratio17.82×
EPS (TTM)3.91
Income & risk
Dividend / yield—
Beta0.95
Avg volume1.59M
Discussion

GMED News

Stories mentioning GMED from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue759,854826,420769,048745,342598,121657,293625,705629,691
Cost of Goods Sold234,066261,107252,533248,765195,397263,437270,515260,040
Gross Profit525,788565,313516,515496,577402,724393,856355,190369,651
Operating Expenses
Research & Development36,51036,16338,06739,95433,06233,40835,38037,698
Sales General & Admin297,775318,480313,597303,622242,799253,167240,062239,454
Total Operating Expenses320,029
Operating Income (Loss)150,388169,340137,36376,10997,00460,27448,09849,622
Interest Income
Interest Expense
Other Expense2,247391.001,537772.00713.001,068(570.00)997.00
Pretax Income157,074169,233143,994188,173103,66824,66757,03247,581
Tax Provision32,77228,63925,028(14,673)28,206(1,838)5,19615,821
Net Income (Loss)124,302140,594118,966202,84675,46226,50551,83631,760
Earnings Per Share (Basic)0.921.040.881.500.550.200.380.23
Earnings Per Share (Diluted)0.901.030.881.490.540.190.380.23
Weighted Average Shares Outstanding (Basic)135,364135,215134,502135,205136,757135,726135,615135,195
Weighted Average Shares Outstanding (Diluted)138,191137,056135,394136,499139,774137,863138,062136,979

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About GMED

Globus Medical, Inc. (NYSE: GMED) is a stock listed on the New York Stock Exchange under the ticker symbol GMED. It last traded at $76.37 (Nov 9, 2026, 4:00 PM ET), up 7.5% on the day. That gives Globus Medical a market capitalisation of $9.5B and a price-to-earnings ratio of 17.8.

Over the past 52 weeks GMED has traded between $60.36 and $101.40.

Revenue for the quarter ended Mar 31, 2026 was $759.9M; net income $124.3M. Revenue was up 27.0% from $598.1M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$759.9M$124.3M16.4%
Dec 31, 2025$826.4M$140.6M17.0%
Sep 30, 2025$769.0M$119.0M15.5%
Jun 30, 2025$745.3M$202.8M27.2%

From Globus Medical’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…